Jaguar Health, Inc. 8-K

What Happened
Jaguar Health, Inc. (JAGX) filed an 8-K disclosing that on January 6, 2026 it entered into securities purchase agreements with two accredited investors and issued unsecured promissory notes totaling $350,000. The transaction closed the same day. The company said proceeds will be used for working capital and other general corporate purposes.

Key Details

• Issued $350,000 aggregate principal amount of unsecured promissory notes to two accredited investors; transaction closed January 6, 2026.
• Notes bear interest at 6.0% per annum and mature one month after issuance; prepayment permitted without penalty.
• Investors received warrants to purchase up to 350,000 shares of common stock at an initial exercise price of $1.00 per share (subject to standard adjustments).
• Warrants are exercisable immediately and expire on the earlier of five years from issuance, a fundamental transaction, or a liquidation event. The filing notes this was an unregistered private placement.

Why It Matters
This transaction creates a short-term debt obligation and provides immediate cash for Jaguar Health’s working capital needs. The 6% one-month notes are relatively small and short-dated, but the issued warrants represent potential dilution of up to 350,000 shares if exercised. Investors should note both the added short-term liability and the latent equity dilution when assessing near-term capital structure and share count.